Hemp Industry Daily reports….

Toronto-headquartered Ramm Pharma, a company with medical cannabis manufacturing operations in Uruguay, said last week that the Peruvian Ministry of Health approved its Epifractán 5% CBD product “for sale in pharmacies throughout the country for various indications as prescribed by a medical doctor.”


Peru opens the door to CBD medicines, with commercialization imminent

This might be of interest too….

Cannabis culture: a Latin American perspective